| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI0268551 |
| P8608 | Fatcat ID | release_ug7jni6igze73imbnfa2x3edse |
| P698 | PubMed publication ID | 12484775 |
| P2093 | author name string | Loredana Quadro | |
| Silke Vogel | |||
| Roseann Piantedosi | |||
| William S. Blaner | |||
| Yuko Kako | |||
| Ira J. Goldberg | |||
| Max E. Gottesman | |||
| Sheila M. O'Byrne | |||
| P433 | issue | 51 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Retinol binding protein 4, plasma | Q14911603 |
| P304 | page(s) | 15360–15368 | |
| P577 | publication date | 2002-12-24 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | Retinol-binding protein-deficient mice: biochemical basis for impaired vision | |
| P478 | volume | 41 |
| Q89000215 | A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle |
| Q33777110 | Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation |
| Q45208059 | Accumulation of retinol in the liver after prolonged hyporetinolemia in the vitamin A-sufficient rat. |
| Q33758267 | Cholesterol in the retina: the best is yet to come. |
| Q34352004 | Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake |
| Q92915328 | Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey |
| Q34609620 | Conversion of beta-carotene to retinal pigment |
| Q45870879 | Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development |
| Q36766800 | Delivery of retinoid-based therapies to target tissues |
| Q91954772 | Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis |
| Q36591612 | Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents |
| Q36885169 | Effects of dietary retinoids and carotenoids on immune development |
| Q33830710 | Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury |
| Q33692420 | Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model. |
| Q89043651 | Genetically modified mouse models to study hepatic neutral lipid mobilization |
| Q28303846 | Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M |
| Q50876054 | Impaired Rhodopsin Generation in the Rat Model of Diabetic Retinopathy. |
| Q35146299 | Iron, lipocalin, and kidney epithelia |
| Q35250196 | Maternal-fetal transfer and metabolism of vitamin A and its precursor β-carotene in the developing tissues |
| Q37132869 | Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids |
| Q28587431 | Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina |
| Q33783505 | Multiple pathways ensure retinoid delivery to milk: studies in genetically modified mice |
| Q24811718 | Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. |
| Q34074393 | Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment |
| Q46846446 | Preservation of retinoid influx into eye tissues of ABCR-deficient mice |
| Q36639523 | Real-time analyses of retinol transport by the membrane receptor of plasma retinol binding protein |
| Q41787315 | Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways |
| Q34352763 | Regulation of intermediary metabolism by the PKCδ signalosome in mitochondria |
| Q35581406 | Retinoid cycle in the vertebrate retina: experimental approaches and mechanisms of isomerization. |
| Q28506438 | Retinoids and spermatogenesis: lessons from mutant mice lacking the plasma retinol binding protein |
| Q37533328 | The membrane receptor for plasma retinol-binding protein, a new type of cell-surface receptor |
| Q35571339 | Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models |
| Q41209019 | Vitamin A Supplementation Increases the Uptake of Chylomicron Retinyl Esters into the Brain of Neonatal Rats Raised under Vitamin A-Marginal Conditions. |
| Q35189371 | Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases |
| Q34591540 | Vitamin A metabolism: an update |
| Q34655991 | Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo |
Search more.